Jemincare group has completed the Phase I clinical trial of it...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SHANGHAI, Sept. 14, 2021 /PRNewswire-AsiaNet/ -- Recently, Jemincare group has declared that it has completed phase I clinical trial of self-developed novel coronavirus specific neutralizing antibody (Project code: JMB2002). The clinical trial of JMB2002 was stated in January 2021. A single-...
Authors: LATEST ASIANET NEWS RELEASES